More tools:Markets·Screener·Research·Chat

Cardlytics, Inc. Common Stock (CDLX) Financial Statements

Cardlytics, Inc. Common Stock
SIC 7370 · SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
FIGI BBG00225ZDF8
XNAS · usd
3.73▼ 0.01 (-0.27%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close3.74
Day's Range3.55 – 3.80
52-Week Range0.55 – 6.40
Volume29.6K
Avg Volume38.8K
Share Statistics
Shares Outstanding
Employees275
ExchangeXNAS
Listed2018-02-09
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Cardlytics, Inc. Common Stock (CDLX)
What is Cardlytics, Inc. Common Stock's Market Cap?
Cardlytics, Inc. Common Stock's Market Cap is $22.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's Enterprise Value?
Cardlytics, Inc. Common Stock's Enterprise Value is $178.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's Price / Sales?
Cardlytics, Inc. Common Stock's Price / Sales is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's EV / Revenue?
Cardlytics, Inc. Common Stock's EV / Revenue is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's EV / EBITDA?
Cardlytics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's Revenue (TTM)?
Cardlytics, Inc. Common Stock's Revenue (TTM) is $169.1M, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's Net Income (TTM)?
Cardlytics, Inc. Common Stock's Net Income (TTM) is -$100.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's EBITDA?
Cardlytics, Inc. Common Stock's EBITDA is -$73.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's Diluted EPS (TTM)?
Cardlytics, Inc. Common Stock's Diluted EPS (TTM) is -17.03, based on as-reported figures from SEC (XBRL) filings.
What is Cardlytics, Inc. Common Stock's EBITDA Margin?
Cardlytics, Inc. Common Stock's EBITDA Margin is -43.6%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
YoY growth-36.5%-39.2%-24.2%-22.4%
Partner Share and other third-party costs
Delivery costs
Sales and marketing expense
Research and development expense
General and administrative expense
Change in contingent consideration
Loss (gain) on divestiture—
Depreciation and amortization expense
Total costs and expenses
% of revenue114.8%124.1%110.9%232.3%
Operating loss
% of revenue-14.8%-24.1%-10.9%-132.3%
Other (expense) income:
Interest expense, net
Loss on investments——
Foreign currency gain (loss)
Total other (expense) income
Loss before income taxes from continuing operations
Income tax benefit——
Loss from continuing operations——
(Loss) income from discontinued operations——
Net loss
% of revenue-40.3%-13.1%-14.7%-139.7%